title: Management of type 2 diabetes in youth: an update.
abstract: Although type 1 diabetes historically has been more common in patients eight to 19 years of age, type 2 diabetes is emerging as an important disease in this group. Type 2 diabetes accounts for 8 to 45 percent of new childhood diabetes. This article is an update from the National Diabetes Education Program on the management of type 2 diabetes in youth. High-risk youths older than 10 years have a body mass index greater than the 85th percentile for age and sex plus two additional risk factors (i.e., family history, high-risk ethnicity, acanthosis nigricans, polycystic ovary syndrome, hypertension, or dyslipidemia). Reducing overweight and impaired glucose tolerance with increased physical activity and healthier eating habits may help prevent or delay the development of type 2 diabetes in high-risk youths. The American Academy of Pediatrics does not recommend population-based screening of high-risk youths; however, physicians should closely monitor these patients because early diagnosis may be beneficial. The American Diabetes Association recommends screening high-risk youths every two years with a fasting plasma glucose test. Patients diagnosed with diabetes should receive self-management education, behavior interventions to promote healthy eating and physical activity, appropriate therapy for hyperglycemia (usually metformin and insulin), and treatment of comorbidities.
authors: Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA. peter223@umn.edu
authors: Kevin
authors: K
authors: Peterson
authors: Janet
authors: J
authors: Silverstein
authors: Francine
authors: F
authors: Kaufman
authors: Elizabeth
authors: E
authors: Warren-Boulton
mesh_terms: D000293:Adolescent; D002648:Child; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D015444:Exercise; D005247:Feeding Behavior; D005951:Glucose Tolerance Test; D040261:Harm Reduction; D006801:Humans; D008019:Life Style; D009765:Obesity / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D010353:Patient Education as Topic; D011236:Prediabetic State / Q000453:epidemiology / Q000628:therapy*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology